Comments and Letters

  • Comments on EHR Certification 2014 Edition

    May 04, 2012
      May 4, 2012 Dr. Farzad Mostashari, National Coordinator for Health Information Technology Office of the National Coordinator for Health Information Technology Department of Health and Human Services Attn: 2014 Edition EHR Standards and Certification Criteria Proposed Rule Hubert H. Humphrey Building, Ste. 729D 200 Independence Avenue SW Washington, DC 20201 RE: RIN 0991-AB82: Health Information Technology: Standards, Implementation Specifications, and Certification Criteria forContinue Reading »...
  • Comments on Overpayments Proposed Rule

    April 16, 2012
      April 16, 2012 Ms. Marilyn Tavenner, Acting Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attention: CMS-6037-P P.O. Box 8013 Baltimore, Maryland 21244-8013 RE: RIN 0938-AQ58: Medicare Program; Reporting and Returning Overpayments Dear Ms. Tavenner, The American Clinical Laboratory Association (“ACLA”) appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services’ (“CMS’s” or “the agency’s”)Continue Reading »...
  • Comments Regarding Appropriate Use of Clinical Laboratory Testing

    April 04, 2012
      April 4, 2012 ACLA Comments on Choosing Wisely and Appropriate Use of Clinical Laboratory Testing Statement: The American Clinical Laboratory Association welcomes the Choosing Wisely effort and is now reviewing the report. We applaud continued efforts by physicians and medical groups to bring their expertise and evidence to bear in the effort to encourage appropriate utilization of medical testing. We note that mostContinue Reading »...
  • Letter to HHS on ICD-10 Implementation

    March 28, 2012
    March 28, 2012 The Honorable Kathleen Sebelius Secretary Department of Health and Human Services Room 445-G Hubert H. Humphrey Building 200 Independence Avenue, S.W. Washington, DC 20201 Re: ICD-10-CM Implementation Dear Secretary Sebelius, I am writing to you on behalf of the American Clinical Laboratory Association (ACLA) to urge the Department of Health and Human Services (HHS) to adopt several important recommendations as theContinue Reading »...
  • Letter to Reps Kind and Price Regarding Health Information Technology Reform Act

    March 14, 2012
      March 14, 2012 The Honorable Ron Kind 1406 Longworth House Office Building Washington, DC 20515 The Honorable Tom Price 403 Cannon House Office Building Washington, DC 20515 Dear Congressmen Kind and Price: On behalf of the American Clinical Laboratory Association (ACLA), I am writing in support of the Health Information Technology Reform Act, HR 4066, which seeks to exclude pathologists from incentive paymentsContinue Reading »...
  • Letter to Speaker Boehner and Majority Leader Reid Regarding Medicare Clinical Laboratory Fee Schedule

    March 06, 2012
      March 6, 2012 The Honorable John A. Boehner Speaker U.S. House of Representatives H-232, The Capitol Washington, DC 20515 The Honorable Harry Reid Majority Leader U.S. Senate S-221, The Capitol Washington, DC 20510 Dear Speaker Boehner and Leader Reid: I am writing you today on behalf of the American Clinical Laboratory Association (ACLA), which represents the leading national, regional, esoteric, and pathology clinicalContinue Reading »...
  • Comments Regarding Sunshine Rule

    February 17, 2012
      February 17, 2012 Centers for Medicare and Medicaid Services Department of Health and Human Services Attention: CMS—5060—-P Mail Stop C4—26—05 7500 Security Boulevard Baltimore, MD 21244-1850 RE: CMS-5060-P Transparency Reports and Reporting of Physician Ownership or Investment Interests Dear Acting Administrator Tavenner: The American Clinical Laboratory Association (ACLA) appreciates the opportunity to provide comments to the Centers for Medicare & Medicaid Services (CMS)Continue Reading »...
  • Comments on Coverage with Evidence Development

    January 18, 2012
      January 18, 2012 Louis Jacques, MD Director, Coverage and Analysis Group Office of Clinical Standards Quality Centers for Medicare and Medicaid Services 7500 Security Blvd Baltimore, Maryland 21244 RE: Coverage with Evidence Development (CED) Public Comment & Solicitation Dear Dr. Jacques, The American Clinical Laboratory Association (“ACLA”) is pleased to have this opportunity to submit comments to the Centers for Medicare and MedicaidContinue Reading »...
  • Comments on J11 Draft LCD for Molecular Diagnostic Tests

    January 16, 2012
      January 16, 2012 Dr. Elaine Jeter Medical Director Palmetto GBA (J11 MAC) P.O. Box 100190 Columbia, South Carolina 29202 RE: Palmetto GBA Draft Local Coverage Determination (LCD) for Molecular Diagnostic Tests (MDT) (DL 32394) Dear Dr. Jeter: The American Clinical Laboratory Association (“ACLA”) hereby submits comments on Palmetto GBA’s (“Palmetto’s”) Draft Local Coverage Determination (“LCD”) for Molecular Diagnostic Tests.1 ACLA is an associationContinue Reading »...
  • Letter to CMS Regarding Saturation Biopsy

    December 10, 2011
        December 10, 2011   Mr. Marc Hartstein, Acting Director Hospital and Ambulatory Policy Group Center for Medicare Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244   Dear Mr. Hartstein:   On behalf of the American Clinical Laboratory Association (“ACLA”), I am writing to express our concerns about CMS’s recent actions with respect to HCPCS code G0416, which isContinue Reading »...
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18